- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Govt Issues Export Guidelines for Doxycycline 100 mg Dispersible Tablets

New Delhi: The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, has issued Public Notice No. 03/2025-26 dated April 24, 2025, formally notifying a new Standard Input Output Norm (SION) under the Chemicals & Allied Products (Product Group A) for Doxycycline 100 mg Dispersible Tablets.
The SION, now listed under serial number A-3685, has been introduced to streamline export processes and establish standardized input-output parameters for the formulation. The notice has been issued in exercise of powers conferred under Paragraph 1.03 of the Foreign Trade Policy, 2023, as amended from time to time.
Key Inputs and Output Norms as per DGFT SION A-3685:
Export Product | Qty. | Sl. No. | Import Items | Qty. allowed. |
Doxycycline 100 mg. Dispersible Tablets (Eq. to Anhydrous Doxycycline 100 mg.) | 1 Number Tablet | I | Doxycycline Monohydrate U.S.P/B.P | 106.13 mg. |
According to the DGFT notification, “The following Standard Input Output Norms (SION) is included in the Handbook of Procedures, 2023 under Appendix 4B, as under:”
The SION is likely to boost competitiveness for Indian exporters catering to global antibiotic markets, particularly in low- and middle-income countries where demand for affordable dispersible antibiotic tablets remains strong.
The notification has come into immediate effect from the date of issue.
To view the official DGFT public notice, click on the link below:
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751